a genetic screening strategy for rapid access to po lyether … · 2 23 abstract 24 polyether...
TRANSCRIPT
1
A Genetic Screening Strategy for Rapid Access to Polyether 1
Ionophore Producers and Products in Actinomycetes 2
3
Running title: A GENETIC SCREENING STRATEGY FOR POLYETHER 4
IONOPHORES 5
6
Hao Wang#, Ning Liu
#, Lijun Xi, Xiaoying Rong, Jisheng Ruan, and Ying Huang* 7
8
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy 9
of Sciences, Beijing 100101, P. R. China 10
11
# Hao Wang and Ning Liu contributed equally to this publication. 12
* Corresponding author. Mailing address: State Key Laboratory of Microbial Resources, 13
Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. 14
Phone\Fax: 86 (0) 10 6480 7311. E-mail: [email protected] 15
16
17
18
19
20
21
22
Copyright © 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.Appl. Environ. Microbiol. doi:10.1128/AEM.02915-10 AEM Accepts, published online ahead of print on 18 March 2011
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
2
ABSTRACT 23
Polyether ionophores are a unique class of polyketides with broad-spectrum activity and 24
outstanding potency for the control of drug-resistant bacteria and parasites, and are 25
exclusively produced by actinomycetes. A special epoxidase gene encoding a critical 26
tailoring enzyme involved in the biosynthesis of these compounds has been found in all of 27
the five so far published complete gene clusters of polyether ionophores. To detect potential 28
producer strains of these antibiotics, a pair of degenerate primers was designed according to 29
the conserved regions of the five known polyether epoxidases. A total of 44 putative 30
polyether epoxidase gene-positive strains were obtained by PCR-based screening of 1068 31
actinomycetes isolated from eight different habitats and 236 reference strains encompassing 32
eight major families of Actinomycetales. The isolates spanned a wide taxonomic diversity 33
based on 16S rRNA gene analysis, and actinomycetes isolated from acidic soils seemed to 34
be a promising source of polyether ionophores. Four genera were detected to contain 35
putative polyether epoxidases, including Micromonospora which has not previously been 36
reported to produce polyether ionophores. The designed primers also detected putative 37
epoxidase genes from diverse known producer strains that produce polyether ionophores 38
unrelated to the five published gene clusters. Moreover, phylogenetic and chemical 39
analyses showed a strong correlation between the sequence of polyether epoxidases and the 40
structure of encoded polyethers. Thirteen positive isolates were proved to be polyether 41
ionophore producers as expected, and two new analogues were found. These results 42
demonstrate the feasibility of using this epoxidase gene screening strategy to help rapid 43
identification of known and discovery of unknown polyether products in actinomycetes. 44
45
Keywords: actinomycetes, polyether ionophore, epoxidase, phylogenetic analysis, 46
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
3
PCR-based screening 47
48
INTRODUCTION 49
Programs aimed at the discovery of new secondary metabolites with interesting 50
biological activities from microbial sources have found an impressive number of 51
compounds over the past 50 years. Actinomycetes represent one of the most prolific 52
microbial sources for the discovery of bioactive metabolites (4, 6), many of which are 53
produced by polyketide synthase (PKS) systems (4, 43). Polyether ionophores (Fig. 1) are a 54
unique class of type I polyketides with high degree of promise for the control of 55
drug-resistant bacteria and parasites, and have been widely used as effective veterinary 56
drugs and food additives in animal husbandry (14). These molecules also show a broad 57
spectrum of bioactivity including antifungal, antiviral, antitumor, herbicidal and 58
anti-inflammatory, as well as effects on the central nervous system (CNS) and 59
immunoregulatory systems (25). The ability of polyethers to transport cations across 60
plasma membranes leads to depolarization and cell death. To date, over 120 polyether 61
ionophore structures have been characterized (17) of nearly 10,000 polyketides so far found 62
(27). Without exception, all the known polyether ionophores are produced by 63
actinomycetes, with the vast majority derived from the genera Streptomyces and 64
Actinomadura (17), and the rest from Actinomyces, Dactylosporangium, Nocardia and 65
Nocardiopsis. 66
Despite the long history of use this class of drugs, until recently the biosynthetic pathway 67
remained relatively obscure. However, five complete polyether ionophore gene clusters 68
have now been cloned and fully sequenced: monensin (32), nanchangmycin (44), nigericin 69
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
4
(21), tetronomycin (12) and lasalocid (35, 42). The complete polyether ionophore gene 70
clusters contain a conserved tailoring enzyme gene encoding a flavin-linked epoxidase, 71
which is responsible for the epoxidation of unsaturated polyether intermediates. Disruption 72
of monCI, an epoxidase involved in the biosynthesis of monensin, led to the isolation and 73
characterization of a triene shunt metabolite, confirming its role (7). Given that genes 74
involved in the same biosynthetic pathway tend to cluster together in a chromosome, and 75
that secondary metabolites with similar structures are likely to be biosynthesized by gene 76
clusters that harbor certain homologous genes (13, 33), such genes could serve as markers 77
in the identification and cloning of related gene clusters. KS domain-based PCR approaches 78
are well-established and highly-precedented in the identification and cloning of type I PKS 79
gene clusters in bacteria (19, 37). However, KS-based primers may identify all modular 80
PKS, while genome sequencing of actinomycetes has revealed that a single genome houses 81
in general a large number of such clusters, hence more selective primers targeting the 82
polyether epoxidase gene are needed in the search for polyether ionophore gene clusters 83
and products. 84
Here we describe a PCR-based screening strategy for detecting polyether ionophore 85
producers in actinomycetes. Designed primers enabled the cloning of an approximately 86
700-bp PCR fragment of the polyether epoxidase gene. Distribution of this gene among 87
actinomycetes from different habitats and taxa were represented, and several polyether 88
ionophores were identified from the producer strains. The results further suggest that 89
phylogenetic analyses of putative polyether epoxidase sof the positive strains can provide a 90
guide for the discovery of novel polyether ionophores. 91
92
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
5
MATERIALS AND METHODS 93
Strains and culture conditions. 1068 actinomycetes previously isolated from samples 94
collected from eight different habitats were screened. The former four in Table 1 are 95
considered to be terrestrial samples and the latter four to be marine samples. 236 reference 96
strains of 35 genera, eight major families of Actinomycetales that represented the most 97
productive producers of polyketides (2-3, 8) were also screened. The majority of strains 98
were incubated on GYM agar (JCM medium 43) plates for 7-14 days at 28°C, and the rest 99
on appropriate media such as oatmeal agar (JCM medium 51), yeast-starch agar (JCM 100
medium 42) and Bennett’s agar (JCM medium 44). Most strains were cultivated at pH 7.3, 101
except that acidic soil isolates and Streptacidiphilus strains were resuscitated at pH 5.0. 102
Primer design and PCR amplifications of putative polyether epoxidase genes and 103
16S rRNA genes. Amino acid and DNA sequences of the five known polyether epoxidases 104
(lasalocid, monensin, nanchangmycin, nigericin and tetronomycin), and other 105
non-polyether epoxidases such as PimD, MycG, OleP, ChmPI (1) and flavin-dependent 106
epoxidases were retrieved from GenBank for primer design. Sequence alignments were 107
carried out using the multiple alignment program Clustal W (31). A pair of degenerate 108
primers EPO-F (5’-GGSTGGCARYAYCGYTTYCC-3’) and EPO-R 109
(5’-SCCRTGSCCGTRSAYSGGRTTG-3’) was designed according to the conserved 110
regions of the five known polyether epoxidases (Fig. 2). Universal primers 27F and 1492R 111
(30) were used to amplify the 16S rRNA gene. 112
Total genomic DNAs from actinomycetes used in this study were extracted and purified 113
as previously described by Hopwood et al. (22). PCR amplifications of polyether epoxidase 114
and 16S rRNA genes were performed in a final volume of 50 µl containing 0.4 µmol of 115
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
6
each primer, 0.2 mmol of each of the four dNTPs, 1 µl of extracted DNA, 5 unit of Taq 116
polymerase (with its recommended reaction buffer) and 3 µl of DMSO. The thermal cycler 117
(SensoQuest Labcycler) for amplification of epoxidase genes was programmed according 118
to the following parameters: 95°C for 8 min; 32 cycles at 95°C for 45 sec, 59°C for 45 sec, 119
and 72°C for 1 min; and 72°C for 10 min followed by cooling to 4°C. PCR amplification of 120
16S rRNA genes was performed at: 95°C for 4 min; 30 cycles at 95°C for 45 sec, 55°C for 121
45 sec, and 72°C for 1.5 min; and 72°C for 10 min. Fragments with the expected sizes of 122
approximately 700 bp for epoxidase genes were purified, cloned and sequenced using 123
standard methods. PCR products of 16S rRNA genes were purified and sequenced directly. 124
Phylogenetic analysis. The sequencing results were analyzed using BLASTP and 125
BLASTN accessed through the National Center for Biotechnology Information (NCBI) 126
web site. Sequences showing >40% amino acid identity to known polyether epoxidases 127
were considered to be target genes. Phylogenetic analyses of amino acid sequences of the 128
target epoxidases and 16S rRNA gene sequences of strains identified as positive for the 129
polyether epoxidase gene were conducted respectively using MEGA 4.0 (46), and 130
neighbor-joining trees (40) were constructed with 2000 bootstrap replicates. Epoxidase 131
AmbJ served as outgroup in the phylogenetic tree of polyether epoxidases. The nucleotide 132
sequences that encoded putative polyether epoxidases and 16S rRNA genes (>1350 bp) of 133
strains identified as positive for the polyether epoxidase gene were deposited in the 134
GenBank database under the accession numbers listed in supplemental Table S1. 135
Taxonomic diversity analysis of isolates from different habitats. About 30% of the 136
isolates from each of the eight habitats were randomly selected for 16S rRNA gene 137
sequencing. Partial 16S rRNA gene sequences (600 bp) containing variable regions V1 to 138
V4 (positions 94 to 694 in the Escherichia coli numbering system) (38) were aligned using 139
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
7
Clustal X (31) and binned into groups of related sequences using the web based tool 140
Clusterer (26) with a distance parameter setting =30. Given that the length of 16S rRNA 141
gene sequences used for this purpose were 600 bp, the distribution 30 of the distance setting 142
created sequence clusters that shared at least 95% identity. Each singleton and cluster was 143
defined as an Operational Taxonomic Unit (OTU) (24). One sequence from each OTU was 144
used to construct a phylogenetic tree with related reference sequences as described above. 145
Fermentation, extraction and chemical analysis. Strains identified as positive for the 146
polyether epoxidase gene were fermented either in liquid broth in 500 ml shake flasks 147
(170-180 rpm) or on solid agar in petri dishes at 28°C for 7 days using two media, GYM 148
(JCM medium 43) and SGG (starch 1%, glucose 1%, glycerol 1%, corn steep powder 149
0.25%, peptone 0.5%, yeast extract 0.2%, NaCl 0.1%, CaCO3 0.3% in tap water) (39). 100 150
ml liquid fermentation samples were centrifuged to separate the mycelium and supernatant; 151
the mycelium was extracted once with 50 ml acetone and the supernatant was extracted 152
three times with 100 ml EtOAc. 100 ml solid fermentation samples were mashed and 153
extracted three times with 100 ml ethanol. Different organic phases for each sample were 154
pooled and the entire organic layer was concentrated to dryness in vacuum, and then the 155
residue was re-dissolved in 2 ml DMSO. 2 µl dissolved residues were used to test the 156
activity against Staphylococcus aureus subsp. aureus CGMCC 1.2386 and Bacillus subtilis 157
CGMCC 1.2428. 20 µl of each active extract was subjected to HPLC-UV-MS/MS analysis 158
(Shimadzu SPD-M20A and Thermo-Finnigan LCQ DECA XP) with a linear gradient of 50 159
to 100% aqueous methanol over 25 min (Xbridge ODS; 4.6×150-mm column; flow 1.0 160
ml/min; PDA detector, 190 to 800 nm). Mass spectra were collected (scanning 200 to 2,000 161
atomic mass units) in both positive and negative modes (ESI voltage, 6.0 kV; capillary 162
temperature, 275°C; sheath gas pressure, 12 units and 150 lb/in2, respectively). Compounds 163
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
8
were identified by comparison of molecular weights, UV spectra and retention times with 164
published chemical data from standard databases (e.g. DNP 2008, SciFinder 2007) and 165
references. Extracts showing no UV absorbance were submitted to TLC-MS analysis using 166
Silica-gel 60 F254 (MERCK). 167
Large scale solid fermentation was carried out for strains DSM 41766T (12 L), FXJ1.076 168
(12 L) and FXJ1.264 (25 L), respectively. The fermentation samples were extracted three 169
times with ethanol, and the combined extracts were then subjected to repeated silica gel 170
(Qingdao Haiyang Chemical, 100-200 mesh) and Sephadex LH-20 column 171
chromatographies. The chemical structures of the purified compounds were determined by 172
MS and NMR (Bruker 400 MHz or Bruker 600 MHz) spectroscopic analyses. 173
Antimicrobial Assays. Antimicrobial activity of etheromycin and compound 1.264-B 174
against bacteria and fungi were determined using liquid cultures in 96-well plates (Costar 175
3599, Corning Inc.), according to the method described by Liu et al (34). Indicator strains 176
Bacillus subtilis CGMCC 1.2428, E. coli CGMCC 1.2385, Staphylococcus aureus CGMCC 177
1.2386, Candidia albicans CGMCC 2.538 and Candida pseudorugosa CGMCC 2.3107 178
were obtained from China General Microbiological Culture Collection Center; 179
drug-resistant indicator strains E. coli EMBL 4-1, Klebsiella pneumoniae 5-1, 180
Pseudomonas aeruginosa 6-1 and Staphylococcus aureus MRSA 1-1 were obtained from 181
Weifang Medical University, China. All the indicator strains were incubated in LB broth at 182
37 °C for 24 h, and diluted to 105-10
6 cells/ml using LB broth thereafter. 200 µL of each of 183
the dilutions and 2 µL compound solutions (4 mg/mL as stock solution in DMSO and serial 184
dilutions) were added in triplicate into the 96-well plates, followed by incubation at 37 °C 185
overnight. The absorbance at 600 nm (OD600) was measured by BioTek Synerge H4 to 186
determine the MICs. 187
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
9
188
189
RESULTS 190
Suitability of the primers to amplify polyether epoxidase genes. To evaluate the 191
utility of these primers, three polyether-producing strains, ‘Streptomyces nanchangensis’ 192
NS3226 (nanchangmycin), Streptomyces violaceusniger CGMCC 4.1423T (nigericin) and 193
Streptomyces cinnamonensis CGMCC 4.1619T (monensin) were used as positive controls, 194
and Streptomyces coelicolor A3(2) served as a negative control. Positive PCR products 195
were obtained from the three polyether producers, but not from S. coelicolor A3(2), and 196
were proved to be polyether epoxidase gene fragments nigCI, monCI and nanO 197
respectively by sequencing and BLAST analysis. 198
Furthermore, putative epoxidase gene fragments were identified from another five known 199
producer strains that produce polyether ionophores unrelated to the five published gene 200
clusters: Streptomyces albus subsp. albus JCM 4703 (salinomycin) (36), Actinomadura 201
yumaensis NRRL 12515T (antibiotic X-14868) (28), Actinomadura macra CGMCC 202
4.1513T (antibiotics CP-47433 and CP-47434) (9), Actinomadura fibrosa NRRL 18348
T 203
(antibiotics A-82810) (20) and Dactylosporangium salmoneum ATCC 31222T (antibiotic 204
CP-44161) (10). 205
PCR-based screening of putative polyether epoxidase genes from actinomycetes. 206
PCR-based screening of 1068 actinomycetes isolated from eight different habitats (Table 1) 207
identified 23 (2.2%) putative polyether epoxidase gene-positive strains. Samples from 208
alpine soils collected in Qinghai-Tibet Plateau yielded no positive strains, although over 209
200 isolates were screened. No positive strain was detected from deep sea samples either. 210
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
10
Few putative polyether epoxidase genes were detected in isolates from lakeside soils of 211
Kanas Lake in Xinjiang Province (1.4%), from mangrove sediments in Hainan Province 212
(1.1%) or from coastal sediments in Bohai Bay (1.3%). A comparatively high occurrence of 213
this gene was observed in isolates from sponges in the South China Sea (2.3%) and from 214
medicinal plants in Yunnan Province (3.0%). The highest occurrence of putative polyether 215
epoxidase genes was observed in isolates from acidic soils collected in Jiangxi Province 216
(9.5%). A further 21 positive strains were obtained from 236 reference actinomycetes 217
encompassing eight major families and 35 genera of Actinomycetales (supplemental Table 218
S1 and List S1). The positive strains belong to only three families and four genera: 219
Streptomycetaceae (Streptomyces), Thermomonosporaceae (Actinomadura), 220
Micromonosporaceae (Dactylosporangium and Micromonospora). 221
Phylogenetic analysis of putative polyether epoxidase genes and 16S rRNA genes. 222
Phylogenetic analysis based on protein sequences revealed a large sequence diversity and 223
novelty of the putative polyether epoxidases (Fig. 3), with identities ranging from 40 to 224
97%. Nearly half of the putative polyether epoxidase sequences clustered closely with 225
known ones, supported by high bootstrap values. For instance, sequences from 11 reference 226
strains and two isolates, FXJ1.076 and FXJ23, fell within a large and stable clade with 227
NigCI involved in the biosynthesis of nigericin in Streptomyces violaceusniger, supported 228
by a bootstrap value of 98% and sharing relatively high sequence identities (> 80%). 229
Similarly, sequences from one reference strain and four isolates grouped into another stable 230
clade with NanO involved in the biosynthesis of nanchangmycin in ‘Streptomyces 231
nanchangensis’, and strains DSM 40847T, FXJ1.172 and FXJ6.196 grouped respectively 232
with MonCI, LasC and TmnC that are involved in the biosynthesis of monensin, lasalocid 233
and tetronomycin. Sequences from the other reported polyether producer strains (marked 234
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
11
with ● in Fig. 3) showed significant similarities to the five published epoxidases (with 235
identities of 50-70%), and were located respectively in well-separated clades. It was notable 236
that all the sequences obtained from coastal sediment samples and medicinal plant samples 237
(marked in blue and green in Fig. 3) fell into a well circumscribed clade distantly related 238
with the known epoxidases; in contrast, sequences from acidic soil isolates formed diverse 239
branches interspersed among the whole tree. The topology of the epoxidase tree, where 240
strains of different families and genera were mixed with each other, was completely 241
incongruent with that of the 16S rRNA gene tree (Fig. 4) which clearly separated the four 242
genera of the three families from each other. 243
Taxonomic diversity of isolates from different habitats. Using 95% sequence identity, 244
over half of the 16S rRNA gene sequences from deep see and mangrove sediments fell 245
respectively into one cluster and fewer OTUs were obtained from these two sources than 246
from the others. More OTUs were obtained for sequences from acidic soils and sponges 247
(Table 1). A total of 74 OTUs were obtained, and the phylogenetic analysis (supplemental 248
Fig. S1) indicated that these OTUs covered 29 genera, 14 families and 9 suborders of 249
Actinomycetales. OTUs from each of the terrestrial habitats, from sponges and from coastal 250
sediments were interspersed among almost all these suborders, showing wide taxonomic 251
diversity. Streptomycetaceae, Streptosporangiaceae, Micromonosporaceae, 252
Pseudonocardiaceae and Nocardiaceae represented the majority of OTUs. 253
Chemical identification of polyether ionophores from strains identified as positive 254
for the polyether epoxidase gene. A total of 13 positive strains were examined and shown 255
to produce polyether ionophores (supplemental Table S2). The compound produced by 256
strain FXJ6.196 with a molecular weight of 586 D and maximum UV absorbances at 250 257
and 295 nm, was identified to be tetronomycin by comparison with the data in DNP 2008. 258
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
12
The compound produced by strain FXJ1.172 had a molecular weight of 590 D and a 259
maximum UV absorbance at 304 nm, and showed a MS2 fragmentation pattern identical to 260
that of lasalocid A from the producer strain JCM 3373 (supplemental Table S2), thus was 261
assigned as lasalocid A. Nine strains of the large NigCI epoxidase clade all produced very 262
similar active compounds showing no UV absorbance and the same TLC behaviour, with a 263
molecular weight of 724 D. 13
C-NMR data for the compounds purified from large scale 264
fermentation extracts of strains DSM 41766T and FXJ1.076 (with a high yield of about 0.8 265
g) were the same as follows (CDCl3, 150MHz): 10.8(q, C-38), 13.0(q, C-31), 13.1(q, C-37), 266
13.2(q, C-36), 15.6(q, C-39), 16.3(q, C-33), 17.3(q, C-32), 22.7(q, C-34), 23.3(t, C-6), 267
25.8(t, C-18), 26.0(t, C-5), 27.4(q, C-35), 27.8(d, C-4), 30.9(t, C-19), 31.8(d, C-26), 32.3(t, 268
C-23), 32.6(t, C-10), 35.2(d, C-22), 35.7(t, C-8), 36.7(d, C-12), 37.1(d, C-28), 37.4(t, C-27), 269
39.0(d, C-14), 42.3(t, C-15), 44.2(d, C-2), 57.4(q, C-40), 60.2(d, C-9), 68.2(t, C-30), 69.0(d, 270
C-7), 72.9(d, C-3), 74.6(d, C-24), 77.2(d, C-25), 78.1(d, C-11), 81.7(d, C-17), 82.4(s, C-16), 271
83.5(s, C-21), 85.8(d, C-22), 97.0(s, C-29), 108.2(s, C-13), 177.5(s, C-1). According to the 272
molecular weight and 13
C-NMR results, these compounds were concluded to be nigericin 273
(11). 274
Strain FXJ1.068 produced two polyether-type compounds, 1.068-A and 1.068-B, bearing 275
the same maximum UV absorbance at 234 nm and molecular weights of 866 D and 880 D, 276
respectively. The MSn fragmentation patterns of compound 1.068-A (supplemental Table 277
S3) exhibited high similarity with those of nanchangmycin (45), which strongly indicated 278
this compound to be nanchangmycin or its stereoisomer. The MSn fragmentation patterns of 279
compound 1.068-B (supplemental Table S3) showed remarkable consistency with that of 280
compound 1.068-A, with many fragment ions at m/z 14 higher than their counterparts in 281
compound 1.068-A, and some others identical with those of compound 1.068-A. These 282
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
13
facts led to the assignment of compound 1.068-B as a new analogue of nanchangmycin. 283
However, NMR of compound 1.068-B could not be done because of the low yield. 284
Two purified compounds (1.264-A, 23.6 mg, and 1.264-B, 23.2 mg) were obtained 285
from large scale fermentation of strain FXJ1.264. Compound 1.264-A was determined to 286
be etheromycin by analyses of its ESI-MS and NMR data (Table 2) (41). Compound 287
1.264-B had a similar 13
C-NMR spectrum with 1.264-A, and its molecular formula was 288
determined to be C49H84O16 by analyses of its HRFT-ICRMS spectrum (m/z 927.5659 [M 289
- H]-) and NMR data (Table 2). The
1H,
13C, DEPT, and HSQC spectra of 1.264-B showed 290
49 carbon signals for eleven methyl groups, four methoxy groups, nine methylenes, six 291
methines, eleven oxymethines, one dioxymethine and seven quaternary carbons [including 292
one carboxyl carbon (δC 181.35)]. The planar structure of 1.264-B was established by 293
comparison of the 13
C-NMR spectrum with etheromycin (41) and by further 2D-NMR 294
analysis (KEY 1H-
1H COSY,
1H-
13C HMBC, supplemental Fig. S2). The relative 295
configuration of 1.264-B was established by comparison of the NMR data with 296
etheromycin and 2D-ROESY analysis (supplemental Fig. S2). The 1H and
13C NMR data 297
of rings A-E, ring G were nearly identical with those of etheromycin, revealing their 298
similar configuration. In the 2D-ROESY spectrum, the correlations of C4-methoxy group 299
with H-5, C6-methoxy group with H-4 and the coupling constant of H4 and H5 (J4,5=11.4) 300
revealed that C4-methoxy group and H-5 were on one side of ring A, while C6-methoxy 301
group and H-4 were on the opposite side. The ROE correlation of C16-methoxy group 302
with H-17, H-17 with C20-methoxy and C20-methoxy group with H-21 revealed that they 303
were on the same side of rings C, D and E. Though 1H and
13C NMR data of C-25 were 304
not identical with those of etheromycin, the coupling constants (J24,25 and J25,26) similar 305
with etheromycin and a careful analysis of 2D-ROESY signals of ring F revealed that 306
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
14
1.264-B and etheromycin shared identical relative configuration of ring F. The coupling 307
constants of H-4’ and H-5’(J4’,5’=9.0 or 10.8) of ring G inferred that they were on the 308
opposite sides of the ring, like etheromycin. Due to the existence of C8-methoxy group, 309
the configuration of ring A of 1.264-B should be the same as that of etheromycin (41). In 310
addition, from a biogenetic perspective, the configuration of 1.264-B is considered to be 311
identical with that of the co-occurring etheromycin, with a structure shown in Fig. 1. 312
Among the nine indicator strains, compound 1.264-B showed antimicrobial activity 313
only against the three Gram-positive strains, i.e. Staphylococcus aureus CGMCC 1.2386, 314
Staphylococcus aureus 1-1 and Bacillus subtilis CGMCC 1.2428, with MICs at 1.25, 2.5 315
and 10 µg/mL, respectively. While the corresponding positive control etheromycin 316
(1.264-A) exhibited the same antimicrobial spectrum, but MICs at 0.625~1.25, 0.625 and 317
2.5 µg/mL, respectively. 318
1.264-B: pale yellow oil; IR(KBr) νmax 3425, 2972, 2879, 2935, 2831, 1595, 1458, 319
1377, 11111, 1095, 1072, 1004, 990, 959 cm-1
; 1H and
13C NMR data, see Table 2; 320
HRFT-ICRMS m/z 927.5659[M -H]- (calcd. 927.5686). 321
322
DISCUSSION 323
Enormous efforts have been devoted to the discovery of novel bioactive secondary 324
metabolites in the past 50 years, although only the ‘tip of the iceberg’ of actinomycetes and 325
their antibiotic products has potentially been sampled (5). One of the most important steps 326
for drug discovery from microbial resources is the careful selection of microorganisms. 327
Genetic screening strategies provide a rapid method for cataloguing the biosynthetic 328
potential of microorganisms. In this contribution, the gene of polyether epoxidase, which 329
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
15
has been found to be a key enzyme for polyether biosynthesis, was chosen as a genetic 330
marker for the discovery of polyether ionophores from actinomycetes. Despite that the 331
degenerate primers were designed on the basis of only five polyether epoxidase genes from 332
strepomycetes, these primers also detected epoxidase genes from another five known 333
producer strains that produce polyethers different from the ones used for primer design, 334
including four rare actinomycetes, thus demonstrating a good spectrum of the primers. 335
The PCR screening results showed that detection rates of putative polyether epoxidase 336
genes were a little low, ranging from 0 to 9.5% in isolates from different habitats. Given 337
that only about 120 of more than 10000 actinomycete bioactive metabolites are polyether 338
ionophores and that the incidence of type I PKS in actinomycetes ranges from 30 to 80% 339
(2-3), the low frequency of putative polyether epoxidase genes is considered to be normal. 340
Obviously higher occurrences of putative polyether epoxidase genes were observed in 341
isolates from acidic soils, with greater sequence diversity and novelty than those from other 342
habitats. For the isolates from marine samples, only nine putative polyether epoxidases with 343
low sequence diversity were identified out of more than 500 strains that covered as wide 344
taxonomic diversity as the acidic soil isolates according to 16S rRNA gene analysis, and no 345
positive strain was obtained from deep sea samples. Consequently, marine actinomycetes, 346
which have been taken as a hot research focus for discovering new bioactive metabolites 347
(15-16, 29), may not, however, be the preferred option for polyether ionophore screening, 348
whereas acidophilic actinomycetes would be a better choice. 349
Eight positive rare actinomycetes were identified: four Actinomadura reference strains, 350
two Dactylosporangium reference strains, and two Micromonospora isolates RtII32 and 351
FXJ1.262, four of which had been described to produce polyether ionophores according to 352
the literatures or patents. Micromonospora species have not to our knowledge been 353
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
16
previously reported to be producers of polyether ionophores, thus further characterization 354
of polyether production from these putative epoxidase gene-positive strains will be of high 355
interest. The rest of the 44 positive strains were all found to be Streptomyces spp. Moreover, 356
among the 236 reference strains, occurrences of putative polyether epoxidases were much 357
higher in the Streptomyces genus (15 out of 108 strains, 13.9%) than in rare actinomycete 358
genera as a whole (6 out of 128 strains, 4.7%). It is therefore reasonable to propose that 359
streptomycetes are still the main source of polyether ionophores, while rare actinomycetes 360
mentioned above are also worth consideration. 361
The results of our phylogenetic and chemical analyses showed a strong evolutionary 362
correlation between putative polyether epoxidase genes and the corresponding polyether 363
gene clusters. Four known polyethers were identified (supplemental Table S2) from 364
positive strains that grouped closely with the known producers in the epoxidase phylogeny 365
(Fig. 3): nigericin, lasalocid A, nanchangmycins and tetronomycin were found from strains 366
(FXJ1.076 and eight others, FXJ1.172, FXJ1.068 and FXJ6.196) in the clades of NigCI, 367
LasC, NanO and TmnC respectively. And etheromycin was found from strain FXJ1.264 368
that located loosely at the periphery of the NanO clade. Further evidence of this correlation 369
is the fact that the main chain structures of nigericin, monensin, nanchangmycin, antibiotic 370
X-14868, antibiotic CP-47433/47434, antibiotic A-82810 and etheromycin are quite similar 371
(Fig. 1), and the three clades of NigCI, MonCI, NanO and putative epoxidase from other 372
four producer strains were clustered together into a stable superclade (Fig. 3); while other 373
epoxidases with distinct product structures were clustered discretely, such as LasC and 374
TmnC. These findings suggested that strains contain homologous polyether epoxidases are 375
likely to produce polyethers with similar structures, and vice versa, indicating that the 376
chemical structures of polyether ionophores could be preliminarily predicted by 377
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
17
phylogenetic analysis of the epoxidases involved, as long as there are reference sequences 378
and structures. The screening strategy developed here paves the way for this, although the 379
sequence data might not ensure that the strain contains a full suite of polyether ionophore 380
biosynthetic genes, or that the polyether gene cluster is expressed by the strain. 381
By comparing the expoxidase and 16S rRNA gene analyses, it was easy to find that 382
several isolates producing known polyethers showed distant phylogenetic relationships with 383
reference strains producing the same polyethers, e.g. strains FXJ23 (nigericin), FXJ1.068 384
(nanchangmycin) and FXJ1.172 (lasalocid) did not cluster with respective producer strains 385
for nigericin, nanchangmycin and lasalocid in the 16S rRNA gene tree. And entirely 386
different branch positions were observed for the producer reference strains of rare 387
actinomycetes in the 16S rRNA gene and epoxidase phylogenies. These contrasts indicate 388
that epoxidase genes, possibly accompanied by the corresponding polyether biosynthetic 389
gene clusters, may have undergone widespread horizontal transfer within the actinomycetes. 390
On the other hand, although horizontal gene transfer of epoxidases was evident, some 391
taxonomically closely related strains also carried genes for highly homologous epoxidases, 392
as exemplified by the clade of nigericin producer strains, and strains from coastal sediments 393
and medicinal plants, indicating vertical inheritance of epoxidase genes within 394
actinomycetes as well. 395
Polyketides often establish biological activity by constraints and modifications 396
introduced by tailoring enzymes, which are encoded by genes clustered with the assembly 397
line genes (47). Therefore, tailoring enzyme genes may contain sufficient phylogenetic 398
information for the evolutionary history of corresponding gene clusters, and recent studies 399
on these genes are beginning to give insights into the correlation between tailoring enzymes 400
and corresponding chemical structures of products (18, 23). Our study indicates that a 401
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
18
strong correlation does exist between polyether epoxidases and polyether ionophores, and 402
thus establishes a feasible genetic screening strategy useful for rapid identification of 403
known and discovery of unknown polyether products in actinomycetes. 404
405
ACKNOWLEDGEMENTS 406
We are grateful to Miss. Xiaoxuan Guo and Jing Gong (Institute of Microbiology, CAS) 407
for their assistance in strain cultivation and DNA preparation, and to Drs. Yuanming Luo 408
(Institute of Microbiology, CAS) and Jidong Wang (Hisun Pharmaceutical Co, Ltd) for their 409
help in MS and NMR analyses. We also appreciate the international culture collections 410
CGMCC, DSMZ, JCM, NBRC and NRRL for providing reference strains. 411
This publication was supported by the Natural Science Foundation of China (NSFC, No. 412
30770002) and the National Hi-Tech Research and Development Program of China (grant 413
no. 2007AA09Z420). 414
415
416
REFERENCES 417
1. Anzai, Y., S. Li, M. Chaulagain, K. Kinoshita, F. Kato, J. Montgomery, and D. Sherman. 418
2008. Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in 419
biosynthesis of mycinamicin macrolide antibiotics. Chem. Biol. 15:950-959. 420
2. Ayuso-Sacido, A., and O. Genilloud. 2005. New PCR primers for the screening of NRPS and 421
PKS-I systems in actinomycetes: detection and distribution of these biosynthetic gene sequences 422
in major taxonomic groups. Microb. Ecol. 49:10-24. 423
3. Ayuso, A., D. Clark, I. González, O. Salazar, A. Anderson, and O. Genilloud. 2005. A novel 424
actinomycete strain de-replication approach based on the diversity of polyketide synthase and 425
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
19
nonribosomal peptide synthetase biosynthetic pathways. Appl. Microbiol. Biotechnol. 67:795-806. 426
4. Bérdy, J. 2005. Bioactive microbial metabolites. J. Antibiot. 58:1-26. 427
5. Baltz, R. 2008. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharm. 428
8:557-563. 429
6. Baltz, R. H. 2007. Antimicrobials from actinomycetes: back to the future. Microbe. 2:125-131. 430
7. Bhatt, A., C. Stark, B. Harvey, A. Gallimore, Y. Demydchuk, J. Spencer, J. Staunton, and P. 431
Leadlay. 2005. Accumulation of an E, E, E-triene by the monensin-producing polyketide synthase 432
when oxidative cyclization is blocked. Angew. Chem. Int. Ed. Engl. 44:7075-7078. 433
8. Busti, E., P. Monciardini, L. Cavaletti, R. Bamonte, A. Lazzarini, M. Sosio, and S. Donadio. 434
2006. Antibiotic-producing ability by representatives of a newly discovered lineage of 435
actinomycetes. Microbiol. 152:675-683. 436
9. Celmer, W., W. Cullen, C. Moppett, J. Oscarson, L. Huang, R. Shibakawa, and J. Tone. Apr. 437
1979. Polycyclic ether antibiotics produced by new species of actinomycete. U. S. Patent 438
4148882. 439
10. Comai, K., A. Sullivan, and J. Westley. Nov. 1981. Polyether ionophores as antiobesity and 440
hypotriglyceridemic agents. U. S. Patent 4302450. 441
11. David, L. and L. Ayala. 1985. Abierixin, a new polyether antibiotic production, structrual 442
determination and biological activities. J. Antibiot. 38:1655-1663. 443
12. Demydchuk, Y., Y. Sun, H. Hong, J. Staunton, J. B. Spencer, and P. F. Leadlay. 2008. Analysis 444
of the tetronomycin gene cluster: insights into the biosynthesis of a polyether tetronate antibiotic. 445
ChemBioChem. 9:1136-1145. 446
13. Doc, P. 2003. A genomics-guided approach for discovering and expressing cryptic metabolic 447
pathways. Nat. Biotechnol. 21:187-190. 448
14. Dutton, C., B. Banks, and C. Cooper. 1995. Polyether ionophores. Nat. Prod. Rep. 12: 165-181. 449
15. Fenical, W., and P. Jensen. 2006. Developing a new resource for drug discovery: marine 450
actinomycete bacteria. Nat. Chem. Biol. 2:666-673. 451
16. Fiedler, H., C. Bruntner, A. Bull, A. Ward, M. Goodfellow, O. Potterat, C. Puder, and G. 452
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
20
Mihm. 2005. Marine actinomycetes as a source of novel secondary metabolites. Antonie Van 453
Leeuwenhoek 87:37-42. 454
17. Gallimore, A. 2009. The biosynthesis of polyketide-derived polycyclic ethers. Nat. Prod. Rep. 455
26:266-280. 456
18. Gao, P., and Y. Huang. 2009. Detection and distribution of FADH2-dependent halogenase gene 457
in major filamentous actinomycete taxonomic groups and its phylogenetic implication in 458
organohalogen compound discovery. Appl. Environ. Microbiol. 75:4813-4820. 459
19. Ginolhac, A., C. Jarrin, P. Robe, G. Perrière, T. Vogel, P. Simonet, and R. Nalin. 2005. Type I 460
polyketide synthases may have evolved through horizontal gene transfer. J. Mol. Evol. 461
60:716-725. 462
20. Hamill, R., and R. Yao. Mar. 1992. Process for producing antibiotic A8210 which comprises 463
cultivating Actinomadura Fibrosa sp. nov. NRRL 18348, or an A82810-producing mutant thereof. 464
U. S. Patent 5098834. 465
21. Harvey, B. M., T. Mironenko, Y. Sun, H. Hong, Z. Deng, P. F. Leadlay, K. J. Weissman, and S. 466
F. Haydock. 2007. Insights into polyether biosynthesis from analysis of the nigericin biosynthetic 467
gene cluster in Streptomyces sp. DSM 4137. Chem. Biol. 14:703-714. 468
22. Hopwood, D., M. Bibb, K. Chater, T. Kieser, C. Bruton, H. Kieser, D. Lydiate, C. Smith, J. 469
Ward, and H. Schrempf. 1985. Genetic manipulation of Streptomyces: a laboratory manual. John 470
Innes Foundation, Norwich. 471
23. Huitu, Z., W. Linzhuan, L. Aiming, S. Guizhi, H. Feng, L. Qiuping, W. Yuzhen, X. 472
Huanzhang, G. Qunjie, and W. Yiguang. 2009. PCR screening of 3-amino-5-hydroxybenzoic 473
acid synthase gene leads to identification of ansamycins and AHBA-related antibiotic producers in 474
actinomycetes. J. Appl. Microbiol. 106:755-763. 475
24. Jensen, P., and F. Lauro. 2008. An assessment of actinobacterial diversity in the marine 476
environment. Antonie Van Leeuwenhoek 94:51-62. 477
25. Kevin II, D., D. Meujo, and M. Hamann. 2009. Polyether ionophores: broad-spectrum and 478
promising biologically active molecules for the control of drug-resistant bacteria and parasites. 479
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
21
Expert Opin Drug Discov. 4:109-146. 480
26. Klepac-Ceraj, V., I. Ceraj, and M. Polz. 2006. Clusterer: extendable java application for 481
sequence grouping and cluster analyses. Online J. Bioinf. 7:15-21. 482
27. Koskinen, A. M., and K. Karisalmi. 2005. Polyketide stereotetrads in natural products. Chem. 483
Soc. Rev. 34:677-690. 484
28. Labeda, D., R. Testa, M. Lechevalier, and H. Lechevalier. 1985. Actinomadura yumaensis sp. 485
nov. Int. J. Syst. Bacteriol. 35:333-336. 486
29. Lam, K. 2006. Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. 487
9:245-251. 488
30. Lane, D. J. 1991. 16S/23S rRNA sequencing, p. 115–175. In E. Stackebrandt and M. Goodfellow 489
(ed.), Nucleic acid techniques in bacterial systematics. John Wiley & Sons, Chichester, United 490
Kingdom. 491
31. Larkin, M., G. Blackshields, N. Brown, R. Chenna, P. McGettigan, H. McWilliam, F. 492
Valentin, I. Wallace, A. Wilm, and R. Lopez. 2007. Clustal W and Clustal X version 2.0. 493
Bioinformatics 23:2947-2948. 494
32. Leadlay, P. F., J. Staunton, M. Oliynyk, C. Bisang, J. Cortes, E. Frost, Z. A. Hughes-Thomas, 495
M. A. Jones, S. G. Kendrew, and J. B. Lester. 2001. Engineering of complex polyketide 496
biosynthesis-insights from sequencing of the monensin biosynthetic gene cluster. J. Ind. Microbiol. 497
Biotechnol. 27:360-367. 498
33. Liu, W., J. Ahlert, Q. Gao, E. Wendt-Pienkowski, B. Shen, and J. Thorson. 2003. Rapid PCR 499
amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial 500
classification model. Proc. Natl. Acad. Sci. 100:11959-11963. 501
34. Liu, X. T., P. Qin, S. Yao, I. D. Williams, H.Herman, Y. Sung, Q. Zhang, J. Y. Liang, Y. I. 502
Nancy and Z. D. Min. 2006. ent-Rosane and Labdane Diterpenoids from Sagittaria sagittifolia 503
and Their Antibacterial Activity against Three Oral Pathogens. J. Nat. Prod. 69:255-260. 504
35. Migita, A., M. Watanabe, Y. Hirose, K. Watanabe, T. Tokiwano, H. Kinashi, and H. Oikawa. 505
2009. Identification of a gene cluster of polyether antibiotic lasalocid from Streptomyces 506
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
22
lasaliensis. Biosci. Biotechnol. Biochem. 73:169-176. 507
36. Miyazaki, Y., M. Shibuya, H. Sugawara, O. Kawaguchi, C. Hirose, J. Nagatsu, and S. Esumi. 508
1974. Salinomycin, a new polyether antibiotic. J. Antibiot. 27:814-821. 509
37. Moffitt, M., and B. Neilan. 2003. Evolutionary affiliations within the superfamily of 510
ketosynthases reflect complex pathway associations. J. Mol. Evol. 56:446-457. 511
38. Neefs, J., Y. Van de Peer, P. De Rijk, S. Chapelle, and R. De Wachter. 1993. Compilation of 512
small ribosomal subunit RNA structures. Nucl. Acids Res. 21:3025-3049. 513
39. Riedlinger, J., A. Reicke, H. Zahner, B. Krismer, A. Bull, L. Maldonado, A. Ward, M. 514
Goodfellow, B. Bister, and D. Bischoff. 2004. Abyssomicins, inhibitors of the para-aminobenzoic 515
acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. 57: 253-259. 516
40. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing 517
phylogenetic trees. Mol. Biol. Evol. 4:406-425. 518
41. Seto, H., K. Mizoue, H. Nakayama, K. Furihata, N. Otaka and H. Yonehara. 1978. Studies on 519
the ionophorous antibiotics. XX1)
some emperical rules for structural elucidation of polyether 520
antibiotics by 13
C-nmr spectroscopy. J. Antibiot. 32:239-243. 521
42. Smith, L., H. Hong, J. Spencer, and P. Leadlay. 2008. Analysis of specific mutants in the 522
lasalocid gene cluster: evidence for enzymatic catalysis of a disfavoured polyether ring closure. 523
ChemBiochem. 9:2967-2975. 524
43. Staunton, J., and K. Weissman. 2001. Polyketide biosynthesis: a millennium review. Nat. Prod. 525
Rep. 18:380-416. 526
44. Sun, Y., X. Zhou, H. Dong, G. Tu, M. Wang, B. Wang, and Z. Deng. 2003. A complete gene 527
cluster from Streptomyces nanchangensis NS3226 encoding biosynthesis of the polyether 528
ionophore nanchangmycin. Chem. Biol. 10:431-441. 529
45. Sun, Y. H., and Z. X. Deng. 2003. Genetic and molecular basis for the biosynthesis of antibiotics 530
in streptomyces nanchangensis. Ph.D. thesis. Shanghaijiaotong University. China. 531
46. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: molecular evolutionary genetics 532
analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599. 533
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
23
47. Walsh, C. 2004. Polyketide and nonribosomal peptide antibiotics: modularity and versatility. 534
Science 303:1805-1810.535
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
24
TABLE 1. Epoxidase gene screening results and taxonomic diversity of the isolates from different environmental samples
Strain category Source
No. of
strains
screened
No. of
positive strains
Identity range of
16S rDNA
OTU
singletons
OTU
clusters
OTUs
total
Acidic soils from Jiangxi Province 105 10 (9.5%) 84%~100% 5 8 13
Medicinal plants 101 3 (3.0%) 83%~100% 3 5 8
Alpine soils from Qinghai-Tibet
Plateau 207 0 (0%) 83%~100% 5 5 10
Terrestrial
actinomycetes
Soils from lakeside of Kanas in
Xinjiang 70 1 (1.4%) 82%~100% 5 4 9
Mangrove sediments From Hainan 95 1 (1.1%) 88%~100% 3 3 6
Sponges from South
China Sea 220 5 (2.3%) 83%~100% 7 6 13
Coastal sediments from Bohai Bay,
Dalian 227 3 (1.3%) 81%~100% 3 8 11
Marine-origin
actinomycetes
Deep sea samples from southeast
Indian Ocean 43 0 (0%) 82%~100% 2 2 4
Total 8 1068 23 (2.2%) - 33 41 74
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
25
TABLE 2. NMR (600 MHz, CDCl3) data for the free-acid of 1.264-A (etheromycin) and 1.264-B 1
1.264-A (etheromycin)* 1.264-B Carbon
δC δH (J in Hz) δC δH (J in Hz)
1 COOH 180.8 ― 181.35# ―
2 CH 45.09 2.52, q(7.2) 45.04 2.51, q(7.2)
3 O-C-O 99.5 ― 99.5 ―
4 CH 38.9 1.64, m 38.96 1.66, m
5 O-CH 76.56 3.66, d(11.4) 76.58 3.67, d(11.4)
6 C-O 82.64 ― 82.65 ―
7 O-CH 71.34 3.69, d(10.2) 71.33 3.68, d(11.4)
8 CH 40.1 1.36, m 40.1 1.38, m
9 O-CH 62.9 4.19, m 63.5 4.21, m
10 CH2 32.33 1.38, 1.63, m 32.2 1.39, 1.63, m
11 O-CH 79.8 3.30, m 79.81 3.30, m
12 CH 39.64 1.76, m 40.2 1.76, m
13 O-C-O 109.1 ― 109.05 ―
14 CH2 36.75 1.86, 1.96, m 37 1.93, 1.98, m
15 CH2 32.77 1.61, 1.84, m 32.2 1.70, 1.78, m
16 C-O 86.04 ― 86.8 ―
17 O-CH 82.93 3.76, dd(8.1, 8.1) 82.6 3.90, dd(11.4, 11.4)
18 CH2 24.26 1.73, m 24.8 1.78, 1.86, m
19 CH2 28.6 1.42, 1.92, m 28.63 1.56, m
20 C-O 85.2 ― 85.83 ―
21 O-CH 83.87 4.20, m 83.81 4.34, m
22 CH2 29.74 1.39, 1.98, m 29.65 1.23, 2.14, m
23 CH2 24.36 1.73, 2.12, m 24.82 2.00, m
24 O-CH 80.6 4.30, m 80.69 4.34, m
25 O-CH 73.5 3.93, dd(10.5, 2.1) 76.77 3.57, dd(10.2, 0)
26 CH 39.3 1.26, m 39.56 1.28, m
27 O-CH 84.55 2.95, dd(9.6, 9.6) 84.37 2.90, dd(10.2, 10.2)
28 CH 46.2 1.40, m 46.89 1.45, dq(6.6, 9.6)
29 O-C-O 98.4 ― 100.87 ―
2-Me 11.75 1.04, d(7.2) 11.61 1.05, d(7.2)
4-Me 11.67 0.97, d(6.6) 11.68 0.97, d(6.6)
6-Me 8.04 1.14, s 8.05 1.15, s
8-Me 10.92 0.75, d(7.2) 10.84 0.76, d(7.2)
11-OMe 58.74 3.47, s 58.7 3.41, s
12-Me 13.54 0.98, d(7.2) 13.32 0.96, d(7.2)
16-Me 29.2 1.22, s 27.97 1.53, s
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
26
20-Me 22.55 1.06, s 21.72 1.10, s
26-Me 13.2 0.91, d(6.6) 13 0.94, d(6.6)
27-OMe 59.8 3.39, s 60.19 3.40, s
28-Me 12.37 1.04, d(6.0) 12.17 0.98, d(6.6)
29-Me 26.53 1.28, s 21.9 1.22, s
29-OMe ― ― 48.15 3.13, s
Deoxysugar
1' O-CH-O 95.1 4.58, dd(0, 9.0) 95.11 4.59, dd(1.5, 9.6)
2' CH2 30.44 1.53, 1.78, m 30.5 1.55, 1.78, m
3' CH2 27.25 1.31, 2.13, m 27.3 1.33, 2.15, m
4' O-CH 79.8 2.78, ddd(4.2, 10.8, 13.2) 79.88 2.79, ddd(4.2, 9.0, 10.8)
5' O-CH 74.66 3.36, m 74.72 3.37, m
4'-OMe 56.9 3.32, s 56.91 3.32, s
5'-Me 18.16 1.26, d(6.0) 18.18 1.26, d(6.0)
*, Assignments based on reference (44); #, no carboxyl signal in CDCl3, data obtained in pyridine-d5. 2
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
FIG. 1. Structures of typical polyether ionophores. 1, 4, 7, 9, 11: Compounds
with complete polyether gene clusters published; 6: etheromycin and its new
analogue.
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
ORIGINLasC .MTNTRS......AVVLGGGMAGMLVSSMLARHVGSVTVIDRDAFPAGPDLRKGVPQARHAHILWSGGARIVEELLPGTTDRLLGAGAHRIGIPDGQVSYTA 95MonCI .MTTTRP....AHAVVLGASMAGTLAAHVLARHVDAVTVVERDALPEEPQHRKGVPQARHAHLLWSNGARLIEEMLPGTTDRLLAAGARRLGFPEDLVTLTG 97NanO ...MTTP....TRAVVLGGGWAGMLTAHVLARHLESVTVVERDILPDGPHHRKGQPQARHVHVLWSSGAGIVENLLPGTAERLLAAGARRIGFQSDLVTLTA 95NigCI ...MTEP....KHGVVLGGGWAGMLAAHVLARHLERVTVVERDVLPDGPRHRKGSPQGRHVHVLWSSGARIVDTLLPGMIDQLLDAGARRIGFHQDLVTLTS 95TmnC MAEATRGPNTRVHGVVLGGGLAGVLAARALRDHVDHVTVVERDTYPDLTEPRKGVPQGRHAHILWSGGAEAIEELLPGTLDRLRAAGAHRIGVKEDMVLYSA 102CONSENSUS T VVLG AG L L H VTV RD P RKG PQ RH H LWS GA LPG L AGA R G VLasC YGWQHRFPGWQHRFPGWQHRFPGWQHRFPEAQFMIACSRALLDWTVREETLREERIALVEKTEVLALLGDAG....RVTGVRVRDQESGEEREVPADLVVDTTGRGSPSKRLLAELGLPAPEE 193MonCI QGWQHRFPGWQHRFPGWQHRFPGWQHRFPATQFALVASRPLLDLTVRQQALGADNITVRQRTEAVELTGSGGGSGGRVTGVVVRDLDSGRQEQLEADLVIDATGRGSRLKQWLAALGVPALEE 199NanO WGWQYRFPGWQYRFPGWQYRFPGWQYRFPATAYAMMCTRPLLDWVVRDAILAGGRIEVEHGTEAVELAGDRS....RVTGVRVRDAGGGEPRLLEADLVVDATGRASRLGHWLAALGLPAVEQ 193NigCI HGWQHRFPGWQHRFPGWQHRFPGWQHRFPPRQYALMCTRPFLDWKVRDRVLATGRITLRQRAEILDLAGDAK....RVTGVRVRDMGSGAAETLAADLVIDASGRGSRLRHWLSALDVPPLEE 193TmnC YGWQHRFPGWQHRFPGWQHRFPGWQHRFPGSHYALTCSRPLLDRTVREAALDHPDTEVLTRTEAHGLLGDRT....SVTGVRVRTSD.GATRELPADIVVDATGRGSRLRHWLTDLGLPPAAE 199CONSENSUS GWQ RFPGWQ RFPGWQ RFPGWQ RFP R LD VR L E L G VTGV VR G AD V D GR S L L PLasC EFVDSGMVYATRLFRAPEAAATNFPLVSVHADHRAGRPGCNAVLMPIEDGRWIVTVSGTRGGEPPADDEGFARFARDGVRHPLVGELIAKAQPLTSVERSRS 295MonCI DVVDAGVAYATRLFKAPPGATTHFPAVNIAADDRVREPGRFGVVYPIEGGRWLATLSCTRGAQLPTHEDEFIPFAEN.LNHPILADLLRDAEPLTPVFGSRS 300NanO DVVDAGIGYATRMFKAPEGADGNFPAVQVAADPLTRQPGRFGVVYPQEGGRWLVTLTSTRGAPLPTDEDEFTGYAKV.LRHSIVSELMSVAEPISPIFQSHS 294NigCI DIVDAGIAYATRVYQGPPGAAAGFPAVNVAADHRLREPGRFGVVYPQEDLTWMVTLSCTRGAGLPTHDDEFLPYART.LRHPLVADLIALAKPLTSVAVSRV 294TmnC ESVDTGLTYATRVFRAPAGAPGAFPVVSVYADHRSGEPGRNGLLLPIEDGRWIITLSGTRGGEPTADEERFATFARS.LRDPIIADLIEAAEPLTPVRTTRS 300CONSENSUS VD G YATR P A FP V AD PG P E W T TRG F A L A PLasC TVNRRLHYDRLATWPEGLVVLGDAVAAFNPVYGHGFNPVYGHGFNPVYGHGFNPVYGHGMSAAAHSVLALRSQLGQR.....AFQPGLARAAQRAIAVAVDDAWVLATSHDIGYPGCRTQTRDPRL 392MonCI GANRRLYPERLEQWPDGLLVIGDSLTAFNPIYGHGFNPIYGHGFNPIYGHGFNPIYGHGMSSAARCATTIDREFERSVQEGTGSARAGTRALQKAIGAAVDDPWILAATKDIDYVNCRVSATDPRL 402NanO GANRRMYPERMPQWPEGLLILGDSLAAFNPVYGHGFNPVYGHGFNPVYGHGFNPVYGHGMSSAARAAEALDKELAR.....DGFGEGGTRQVQRALSEVVDDPWIMAGLNDIQYVNCRNLSSDPRL 391NigCI GANRRLYPERLDIWPEGLLVLGDALAAFNPIYGHGFNPIYGHGFNPIYGHGFNPIYGHGMSSAARAAAALDTELQR.....SGTAEGTTRRAQQAISATVDDPWIMAASKDVEYVNCRMNTTDPRL 391TmnC TLNRRMHLDRLADRPEGLVALGDCVVSLNPIHGHGLNPIHGHGLNPIHGHGLNPIHGHGMSVAARSARALEACLSRAG....GLKPGLARTAQQAIAAAADAPWLLSASQDLCYPDNKAAVSDPRL 398CONSENSUS NRR R P GL GD NP GHGNP GHGNP GHGNP GHGMS AA R Q A D W D Y DPRLLasC TR.HAGERQRVTDLVGLTATRNQVVNRAAVALNTLSAGMASMQDPAVMAAVRRGPEVPAPTEPPLRPDEVARLVSGAGVTA............. 472MonCI IGVDTEQRLRFAEAITAASIRSPKASEIVTDVMSLNAPQAELGSNRFLMAMRADERLPELTAPPFLPEELAVVGLDAATISPTPTPTPTAAVRS 496NanO TGPDVAERLKFSDFLSGKSIRSPKVCEVTTSVLSLNAPQKALGDSRFLSLLRTDTSHPKLVEPPFHPEELEMVGLKPSGIAAKGALG....... 478NigCI TG.GAVARQRFSDLIADRSIRSSAVCDVVTDVISLTAPQSELASSGFLSLMHKDRVLPELTEPPLTADELALVNLSPRSAVSAGGS........ 476TmnC TT.QAAQRQGFADMVTSASLVNERVCDALTAVTTLTAPLGSLETPEFLAAMR.QPARPPLTAAPLKDAEAAVLRAAK................. 473CONSENSUS R L A P P E
EPOEPOEPOEPO----F:5'F:5'F:5'F:5'----GGSTGGCARYAYCGYTTYCCGGSTGGCARYAYCGYTTYCCGGSTGGCARYAYCGYTTYCCGGSTGGCARYAYCGYTTYCC----3'3'3'3'EPOEPOEPOEPO----R: 3'R: 3'R: 3'R: 3'----GTTRGGSYASRTGCCSGTRCCSGTTRGGSYASRTGCCSGTRCCSGTTRGGSYASRTGCCSGTRCCSGTTRGGSYASRTGCCSGTRCCS----5'5'5'5'
FIG. 2. Multiple amino acid sequence alignment of the five known polyether
epoxidases (LasC: CAQ64694; MonCI: AAO65803; NanO: AAP42870; NigCI:
ABC84466; TmnC: BAE93732). Conserved regions underlined and marked with
boldface were used for polyether epoxidase gene-specific primer pair design. The
panes indicate designed primers. The directions of arrows represent the directions of
primers.
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
FIG. 3. Neighbour-joining tree of putative polyether epoxidases and five known polyether
epoxidases (marked with boldface). Strains from which polyether products are identified in this
study are marked with ▲; strains producing known polyethers differnet from the five known ones
are marked with ●, and corresponding products are listed behind. Different colors represent
different major sample sources of the positive strains. AmbJ, homolog of polyether epoxidases,
serves as outgroup. Significant bootstrap values (>50%) are indicated at the nodes. The scale bar
represents 0.1 mutational events per site.
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from
FIG. 4. Neighbour-joining tree of 16S rRNA genes from polyether epoxidase gene-positive
strains and four known polyether-producing strains (marked with boldface). Strains from which
polyether products are identified in this study are marked with ▲; strains producing known
polyethers differnet from the five known ones are marked with ●, and corresponding products
are listed behind. Different colors represent different major sample sources of the positive
strains. Significant bootstrap values (>50%) are indicated at the nodes. The scale bar represents
0.01 mutational events per site. Tetronomycin-producing strain and its 16S rRNA gene
sequence were unavailable.
on May 21, 2020 by guest
http://aem.asm
.org/D
ownloaded from